Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Whos on call for you
For indirect comparison (different trials, populations, and durations), semaglutide showed approximately 50% reduction over 72 weeks, and tirzepatide approximately 47% at 52 weeks
Athletes, busy professionals, fatigued patients
Zilbrysq won approval based on the Phase III RAISE study, which assessed the therapy in adults with anti-acetylcholine receptor antibody-positive gMG
US$ 26.38
US$ 24.61
US$ 21.33
US$ 25.57
US$ 25.17
US$ 25.23
US$ 29.74
US$ 25.49
US$ 29.36
US$ 20.25
US$ 26.98
US$ 28.14
US$ 26.75
US$ 29.80
